SV40 Tag DNA sequences, present in a small proportion of human hepatocellular carcinomas, are associated with reduced survival

Journal of Clinical Pathology

Volumn 56, Issue 12, 2003, Pages 904-909

  Wong, N A C S ^a,b   Rae, F ^b   Herriot, M M ^b   Mayer, N J ^b   Brewster, D H ^c   Harrison, D J ^b  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c Scottish Cancer Intelligence Unit   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

POLIOMYELITIS VACCINE; PROTEIN P53; RETINOBLASTOMA PROTEIN; VIRUS LARGE T ANTIGEN;

ADULT; AGED; ALCOHOL LIVER CIRRHOSIS; ARTICLE; CANCER SURVIVAL; COHORT ANALYSIS; DISEASE ASSOCIATION; DNA SEQUENCE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIMIAN VIRUS 40; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ANTIGENS, POLYOMAVIRUS TRANSFORMING; BASE SEQUENCE; CARCINOMA, HEPATOCELLULAR; COHORT STUDIES; DNA, VIRAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYOMAVIRUS INFECTIONS; SIMIAN VIRUS 40; SURVIVAL ANALYSIS; TUMOR VIRUS INFECTIONS;

EID: 0347411019     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.56.12.904     Document Type: Article

References (41)

1. London WT. Liver cancer: a disease of the 21st century in America and Europe; lessons from the 20th century in China and Africa [abstract]. In: Abstracts for 6th European meeting on hepatocarcinogenesis: from basic science to treatment, September 23-25 1999, Vienna, Austria. Vienna: University of Vienna, 1999:11.
2. Anthony PP. Tumours and tumour-like lesions of the liver and biliary tract - aetiology, epidemiology and pathology. In: MacSween RNM, Burt AD, Portmann BC, eds. Pathology of the liver, 4th ed. London: Churchill Livingstone, 2002:711-76.
3. Carbone M, Rizzo P, Pass HI. Simian virus 40, poliovaccines and human tumours: a review of recent developments. Oncogene 1997;15:1877-88.
4. Butel JS, Lednicky JA. Cell and molecular biology of simian virus 40: implications for human infections and disease. J Natl Cancer Inst 1999;91:119-34.
5. Sanger DV, Wood DJ, Minor PD. Examination of poliovaccines for the presence of SV40 sequences. In: Brown F, Lewis AM, eds. Simian virus 40 (SV40): a possible human polyomavirus, Dev Biol Stand, Vol. 94. Basel: Karger, 1998:221-5.
6. Yamamoto H, Nakayama T, Murakami H, et al. High incidence of SV40-like sequence detection in tumour and peripheral blood cells of Japanese osteosarcoma patients. Br J Cancer 2000;82:1677-81.
7. David H, Mendoza S, Konishi T, et al. Simian virus 40 is present in human lymphomas and normal blood. Cancer Lett 2001;162:57-64.
8. Bergsagel DJ, Milton MJ, Butel JS, et al. DNA sequences similar to those of simian virus 40 in ependymomas and choroid plexus tumours of childhood. N Engl J Med 1992;326:988-93.
9. Carbone M, Pass HI, Rizzo P, et al. Simian virus 40-like DNA sequences in human pleural mesothelioma. Oncogene 1994;9:1781-90.
10. Pacini F, Vivaldi A, Santoro M, et al. Simian virus 40-like DNA sequences in human papillary thyroid carcinomas. Oncogene 1998;16:665-9.
11. Vilchez RA, Madden CR, Kozinetz CA, et al. Association between simian virus 40 and non-Hodgkin lymphoma. Lancet 2002;359:817-23.
12. Shivapurkar N, Harada K, Reddy J, et al. Presence of simian virus 40 DNA sequences in human lymphomas. Lancet 2002;359:851-2.
13. Dubois N, Bennoun M, Allemand I, et al. Time-course of development of well differentiated hepatocarcinoma and lung metastasis in transgenic mice. J Hepatol 1991;13:227-39.
14. Held WA, Pazik J, O'Brien JG, et al. Genetic analysis of liver tumorigenesis in SV40 T antigen transgenic mice implies a role for imprinted genes. Cancer Res 1994:6489-95.
15. Casola S, Ungaro P, Pedone PV, et al. Loss of heterozygosity of imprinted genes in SV40 t/T antigen-induced hepatocellular carcinoma. Oncogene 1995;11:711-21.
16. Lee G-H, Ogawa K, Drinkwater NR. Conditional transformation of mouse liver epithelial cells. An in vitro model for analysis of genetic events in hepatocarcinogenesis. Am J Pathol 1995;147:1811-22.
17. Manfredi JJ, Prives C. The transforming activity of simian virus 40 large tumor antigen. Biochim Biophys Acta 1994;1198:65-83.
18. Bannasch P. Pathogenesis of hepatocellular carcinoma: sequential cellular, molecular and metabolic changes. Prog Liver Dis 1996;14:161-97.
19. Nishida N, Fukuda Y, Ishizaki K, et al. Alteration of cell cycle-related genes in hepatocarcinogenesis. Histol Histopathol 1997;12:1019-25.
20. Lednicky JA, Butel JS. Consideration of PCR methods for the detection of SV40 in tissue and DNA specimens. In: Brown F, Lewis AM, eds. Simian virus 40 (SV40): a possible human polyomavirus, Dev Biol Stand, Vol. 94. Basel: Karger, 1998:155-64.
21. Wright DK, Manos MM. Sample preparation from paraffin-embedded tissues. In: Innis M, Gelfand DH, Sninsky JJ, eds. PCR protocols: a guide to methods and applications. London: Academic Press, 1990:153-8.
22. Wong NACS, F Rae, KJ Simpson, et al. Genetic polymorphisms of cytochrome p4502E1 and susceptibility to alcoholic liver disease and hepatocellular carcinoma in a Caucasian population: a study and literature review with meta-analysis. Mol Pathol 2000;53:88-93.
23. Wong NACS, Rae F, Bathgate A, et al. Polymorphisms of the gene for microsomal epoxide hydrolase and susceptibility to alcoholic liver disease and hepatocellular carcinoma. Toxicol Lett 2000;115:17-22.
24. Lednicky JA, Stewart AR, Jenkins JJ III, et al. SV40 DNA in human osteosarcomas show sequence variation among T-antigen genes. Int J Cancer 1997;72:791-800.
25. Reuther FJ, Lohler J, Herms J, et al. Low incidence of SV40-like sequences in ependymal tumours. J Pathol 2001;195:580-5.
26. Gurney EG, Tamowski S, Deppert W. Antigenic binding sites of monoclonal antibodies specific to simian virus 40 large T antigen. J Virol 1986;57:1168-72.
27. Stewart AR, Lednicky JA, Benzick US, et al. Identification of a variable region at the carboxy terminus of SV40 large T-antigen. Virology 1996;221:355-61.
28. Testa JR, Carbone M, Hirvonen A, et al. A multi-institutional study confirms the presence and expression of simian virus 40 in human mesotheliomas. Cancer Res 1998;58:4505-9.
29. Sepulveda AR, Finegold MJ, Smith B, et al. Development of a transgenic mouse system for the analysis of stages in liver carcinogenesis using tissue-specific expression of SV40 large T-antigen controlled by regulatory elements of the human alpha-1-antitrypsin gene. Cancer Res 1989;49:6108-17.
30. Moore M, Teresky AK, Levine AJ, et al. p53 mutations are not selected for in simian virus 40 T-antigen-induced tumors from transgenic mice. J Virol 1992;66:641-9.
31. Hall PA, Lane DP. p53 in tumour pathology: can we trust immunohistochemistry? Revisited! J Pathol 1994;172:1-4.
32. Zhang X, Xu H-J, Murakami Y, et al. Deletions of chromosome 13q, mutations in retinoblastoma 1, and retinoblastoma protein state in human hepatocellular carcinoma. Cancer Res 1994;54:4177-82.
33. Mayall FG, Jacobson G, Wilkins R. Mutations of p53 gene and SV40 sequences in asbestos-associated and non-asbestos-associated mesotheliomas. J Clin Pathol 1999;52:291-3.
34. Carbone M, Rizzo P, Grimley PM, et al. Simian virus-40 large-T antigen binds p53 in human mesotheliomas. Nat Med 1997;3:908-12.
35. Zhen HN, Zhang X, Bu XY, et al. Expression of the simian virus 40 large tumor antigen (Tag) and formation of Tag-p53 and Tag-pRb complexes in human brain tumors. Cancer 1999;86:2124-32.
36. Malkin D, Chilton-MacNeill S, Meister LA, et al. Tissue-specific expression of SV40 in tumors associated with the Li-Fraumeni syndrome. Oncogene 2001;20:4441-9.
37. Procopio A, Strizzi L, Vianale G, et al. Simian virus-40 sequences are a negative prognostic cofactor in patients with malignant pleural mesothelioma. Genes Chromosomes Cancer 2000;29:173-9.
38. Report of the Department of Health for Scotland 1958. Edinburgh: Her Majesty's Stationary Office.
39. Ministry of Health. On the state of the Public Health 1962. London: Her Majesty's Stationary Office.
40. Report of the Department of Health for Scotland 1961. Edinburgh: Her Majesty's Stationary Office.
41. Shah K, Nathanson N. Human exposure to SV40: review and comment. Am J Epidemiol 1976;103:1-12.